PUBLISHER: The Business Research Company | PRODUCT CODE: 1939353
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939353
Bioprocess containers are single-use containers utilized for critical sterile liquid-handling applications in the biopharmaceutical industry. They are employed for liquid cell culture media, reagents, buffers, containment, and storage vessels for intermediate and final products generated from manufacturing processes.
The main types of bioprocess containers include 2D bioprocess containers, 3D bioprocess containers, tank liners, and other containers and accessories. The 2D bioprocess container refers to containers with a two-dimensional design for sterile liquid handling. They are designed for small, simple BPCs ranging from 50 ML to 50 L. These containers are created from two sheets of film, heat-sealed around the perimeter to form a pillow-shaped chamber. Bioprocess containers find applications in biopharmaceutical companies, life science R&D companies, and others for upstream and downstream processes, as well as product development applications.
Tariffs are influencing the bioprocess containers market by increasing costs of imported polymer films, connectors, tubing systems, and precision manufacturing equipment used in single-use containers. Biopharmaceutical producers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on container exports. These tariffs are raising production expenses and supply chain complexity. However, they are also encouraging domestic material sourcing, regional manufacturing expansion, and innovation in alternative bioprocess container materials.
The bioprocess containers market research report is one of a series of new reports from The Business Research Company that provides bioprocess containers market statistics, including bioprocess containers industry global market size, regional shares, competitors with a bioprocess containers market share, detailed bioprocess containers market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess containers industry. This bioprocess containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioprocess containers market size has grown exponentially in recent years. It will grow from $6.39 billion in 2025 to $8.2 billion in 2026 at a compound annual growth rate (CAGR) of 28.4%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing, increasing adoption of disposable bioprocess systems, growth in biologics development, rising demand for sterile processing solutions, availability of advanced polymer materials.
The bioprocess containers market size is expected to see exponential growth in the next few years. It will grow to $22.19 billion in 2030 at a compound annual growth rate (CAGR) of 28.3%. The growth in the forecast period can be attributed to increasing investments in cell and gene therapy manufacturing, rising focus on modular bioprocess facilities, expansion of contract biomanufacturing, growing emphasis on sustainability in bioprocessing, increasing demand for scalable production platforms. Major trends in the forecast period include increasing adoption of single-use bioprocessing systems, rising demand for flexible and scalable biomanufacturing, growing use of sterile liquid handling solutions, expansion of cell and gene therapy production, enhanced focus on contamination risk reduction.
Anticipated growth in the demand for biologics and biosimilars is poised to drive the bioprocess containers market. These innovative medications, used for various medical conditions, are witnessing increased adoption. Bioprocess containers, particularly those tailored for single-use applications, present notable advantages in terms of flexibility, scalability, cost-effectiveness, and reduced contamination risks. For instance, in October 2025, according to the U.S. Food and Drug Administration (FDA), a US-based has authorized 76 biosimilars, representing only a small share of the total approved biologics. This trend is expected to shape the trajectory of the bioprocess container market in response to the expanding demand and usage of biologics and biosimilars.
Major players in the bioprocess containers market are developing advanced high-strength, leak-resistant multilayer films to improve container durability, reduce contamination risk, and support large-volume biologics manufacturing. These films feature reinforced polymer architectures for superior tensile strength, puncture resistance, and low extractables compared to traditional single-use materials. In April 2023, Merck KGaA launched the Ultimus Single-Use Process Container Film, combining a woven-nylon strength layer with medical-grade polyethylene and gas-barrier components. The film provides up to ten times greater abrasion resistance and enhanced leak prevention, ensuring safer handling of high-value biologics while maintaining compatibility with Merck's Mobius(R) 3D bioprocess containers.
In May 2024, Novo Holdings, an investment company based in Denmark, acquired Single Use Support for an undisclosed sum. This acquisition aims to enhance Novo Holdings' life sciences services and manufacturing capabilities, enabling them to better assist pharmaceutical companies in managing biologics and advanced therapies. Single Use Support is a life sciences tools company located in Austria, specializing in fluid management services designed for the pharmaceutical industry, with a focus on the fluid and cold-chain management of pharmaceutical substances.
Major companies operating in the bioprocess containers market are Sartorius Stedim Biotech S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius AG, Compagnie de Saint-Gobain S.A., Lonza Group AG, Avantor Inc., Eppendorf AG, Meissner Filtration Products Inc., Corning Incorporated, GE Healthcare Technologies Inc., Fluids Control Inc., Neta Scientific Incorporated, ALLpaQ Packaging Group plc, Kawasumi Laboratories Inc., F.L. Medical SRL, Sani-Tech West Inc., Cellon SA, Celltainer Biotech BV, Entegris Inc., Flexboy AG, GE Healthcare Life Sciences, GEA Group AG, GEMU Group, GVS Group Ltd., Integra Companies, Kuhner AG
North America was the largest region in the bioprocess containers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess containers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioprocess containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bioprocess containers market consists of sales of Standard BioProcess Containers, Bioprocessing Films, Fluid Transfer Solutions, and Retention Devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioprocess Containers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses bioprocess containers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bioprocess containers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioprocess containers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.